XOMA Corporation (XOMA) |
|
17.85 -0.15 (-0.83%)
|
08-18 06:42 |
|
Open: |
18 |
Pre. Close: |
18 |
|
High:
|
18.17 |
Low:
|
17.64 |
|
Volume:
|
20,268 |
Market Cap:
|
204(M) |
|
|
|
|
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
18.29 - 18.46 |
18.46 - 18.57 |
|
Low:
|
17.27 - 17.5 |
17.5 - 17.64 |
|
Close:
|
17.59 - 17.96 |
17.96 - 18.19 |
|
Technical analysis |
as of: 2022-08-17 4:27:55 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 31.03  One year: 37.48 |
| Support: |
Support1: 17.63 Support2: 14.67 |
| Resistance: |
Resistance1: 26.57 Resistance2: 32.09 |
| Pivot: |
20.72 |
| Moving Average: |
MA(5): 19.09 MA(20): 21.45
MA(100): 21.54 MA(250): 22.76 |
| MACD: |
MACD(12,26): -1.3 Signal(9): -0.8 |
| Stochastic oscillator: |
%K(14,3): 4.9 %D(3): 11.5 |
| RSI: |
RSI(14): 32.5 |
| 52-week: |
High: 32.49 Low: 16.95 |
| Average Vol(K): |
3-Month: 58 (K) 10-Days: 50 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ XOMA ] has closed above bottom band by 7.7%. Bollinger Bands are 4.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 16 Aug 2022
Processa Pharmaceuticals Appoints Khoso Baluch and James Neal to its Board of Directors and ... - KULR-TV
Mon, 15 Aug 2022
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update - Yahoo Finance
Thu, 11 Aug 2022
XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World
Mon, 08 Aug 2022
XOMA Corporation's (NASDAQ:XOMA) market cap dropped US$30m last week; Individual investors bore the brunt - Simply Wall St
Thu, 04 Aug 2022
Form 10-Q XOMA Corp For: Jun 30 - StreetInsider.com
Thu, 04 Aug 2022
XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
11 (M) |
| Shares Float |
8 (M) |
|
% Held by Insiders
|
0.6 (%) |
|
% Held by Institutions
|
59.5 (%) |
|
Shares Short
|
335 (K) |
|
Shares Short P.Month
|
477 (K) |
Stock Financials |
|
EPS
|
1.04 |
|
EPS Est Next Qtl
|
-0.19 |
|
EPS Est This Year
|
-2.94 |
|
EPS Est Next Year
|
-1.33 |
|
Book Value (p.s.)
|
11.81 |
|
Profit Margin (%)
|
45 |
|
Operating Margin (%)
|
49.2 |
|
Return on Assets (ttm)
|
8.6 |
|
Return on Equity (ttm)
|
14.6 |
|
Qtrly Rev. Growth
|
9.1 |
|
Gross Profit (p.s.)
|
3.32 |
|
Sales Per Share
|
3.58 |
|
EBITDA (p.s.)
|
1.76 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
17 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
1.51 |
|
Price to Sales
|
4.97 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2016-10-17 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
